You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

relapsed/refractory AL Amyloidosis

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Light Chain Amyloidosis Trial (FKC288)

Not yet recruiting
  • Light Chain Amyloidosis
  • (no location specified)
Jul 30, 2023

Light Chain (AL) Amyloidosis Trial in Sacramento (NXC-201 CAR-T)

Not yet recruiting
  • Light Chain (AL) Amyloidosis
  • NXC-201 CAR-T
  • Sacramento, California
    University of California Davis Medical Center
Oct 19, 2023

Light Chain (AL) Amyloidosis Trial in New York (STI-6129)

Recruiting
  • Light Chain (AL) Amyloidosis
  • STI-6129
  • Duarte, California
  • +3 more
Jan 12, 2023

Light Chain (AL) Amyloidosis Trial (STI-6129)

Not yet recruiting
  • Light Chain (AL) Amyloidosis
  • STI-6129
  • (no location specified)
Jan 11, 2023

AL Amyloidosis Trial in Worldwide (Belantamab mafodotin)

Recruiting
  • AL Amyloidosis
  • Belantamab mafodotin
  • Limoges, France
  • +5 more
Sep 26, 2022

Amyloid, Amyloidosis, AL Amyloidosis Trial in New York (Selinexor, Dexamethasone)

Suspended
  • Amyloid
  • +2 more
  • New York, New York
    Weill Cornell Medicine - Multiple Myeloma Center
May 17, 2022

AL Amyloidosis, Amyloidosis Trial in Stanford, Boston, Rochester (Belantamab mafodotin 2.5 mg/kg (6 weeks), Belantamab mafodotin

Not yet recruiting
  • AL Amyloidosis
  • Amyloidosis
  • Belantamab mafodotin 2.5 mg/kg (6 weeks)
  • +4 more
  • Stanford, California
  • +3 more
Jul 25, 2022

Amyloidosis, AL Amyloidosis Trial in Worldwide (ZN-d5)

Recruiting
  • Amyloidosis
  • AL Amyloidosis
  • Denver, Colorado
  • +1 more
Jan 18, 2022

AL Amyloidosis Trial in New York (Venetoclax Oral Tablet, 200 mg, FISH assay, Venetoclax Oral Tablet, 400 mg)

Not yet recruiting
  • AL Amyloidosis
  • Venetoclax Oral Tablet, 200 mg
  • +9 more
  • New York, New York
    New York Presbyterian Hospital/Columbia University Irving Medica
Jul 11, 2022

Recurrent AL Amyloidosis, Refractory AL Amyloidosis Trial in Duarte, Boston, Columbus (Bone Marrow Aspiration and Biopsy,

Recruiting
  • Recurrent AL Amyloidosis
  • Refractory AL Amyloidosis
  • Biospecimen Collection
  • +9 more
  • Duarte, California
  • +10 more
Jan 19, 2023

Amyloidosis Trial in France, Italy (Daratumumab)

Completed
  • Amyloidosis
  • Angers, France
  • +9 more
Jul 8, 2021

Relapsed/Refractory Multiple Myeloma, Amyloid Light-chain Amyloidosis Trial (SAR445514)

Not yet recruiting
  • Relapsed/Refractory Multiple Myeloma
  • Amyloid Light-chain Amyloidosis
  • (no location specified)
Apr 20, 2023

AL Amyloidosis Trial in Boston (Venetoclax, Dexamethasone)

Terminated
  • AL Amyloidosis
  • Boston, Massachusetts
    Tufts Medical Center
Aug 19, 2020

Amyloidosis, Light Chain (AL) Amyloidosis Trial (Bendamustine Hydrochloride, Isatuximab)

Withdrawn
  • Amyloidosis
  • Light Chain (AL) Amyloidosis
  • (no location specified)
Dec 29, 2022

Multiple Myeloma, Amyloidosis Trial in Jacksonville, New York, Cleveland (APG-2575+ Pd, APG-2575 + DRd)

Recruiting
  • Multiple Myeloma
  • Amyloidosis
  • APG-2575+ Pd
  • APG-2575 + DRd
  • Jacksonville, Florida
  • +2 more
Feb 28, 2022

AL Amyloidosis Trial in Catanzaro, Pavia, Rome (daratumumab and pomalidomide)

Recruiting
  • AL Amyloidosis
  • daratumumab and pomalidomide
  • Catanzaro, Italy
  • +2 more
Aug 3, 2022

Light-Chain Amyloidosis Trial in Worldwide (Ixazomib, Dexamethasone)

Completed
Has Results
  • Light-Chain Amyloidosis
  • Boston, Massachusetts
  • +9 more
Mar 18, 2020

Amorphous, Eosinophilic, and Acellular Deposit, Constipation, Diarrhea Trial in United States (Isatuximab, Laboratory Biomarker

Active, not recruiting
  • Amorphous, Eosinophilic, and Acellular Deposit
  • +12 more
  • Isatuximab
  • Laboratory Biomarker Analysis
  • Anchorage, Alaska
  • +344 more
Aug 22, 2022

Amyloidosis Trial in United Kingdom (Carfilzomib, Thalidomide, Dexamethasone)

Completed
Has Results
  • Amyloidosis
  • Plymouth, Devon, United Kingdom
  • +13 more
Mar 18, 2021

AL Amyloidosis Trial in France (Isatuximab)

Recruiting
  • AL Amyloidosis
  • Amiens, France
  • +14 more
Aug 9, 2022

Newly Diagnosed Primary Amyloidosis, Recurrent Primary Amyloidosis, Refractory Primary Amyloidosis Trial in Houston

Recruiting
  • Newly Diagnosed Primary Amyloidosis
  • +2 more
  • Daratumumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 12, 2021

AL Amyloidosis Trial in Boston, Detroit, New York (Bendamustine, Dexamethasone)

Completed
Has Results
  • AL Amyloidosis
  • Boston, Massachusetts
  • +5 more
Mar 17, 2020

Recurrent Primary Amyloidosis Trial in United States (drug, biological, other)

Active, not recruiting
  • Recurrent Primary Amyloidosis
  • Duarte, California
  • +4 more
Mar 10, 2021

DLBCL Refractory, Diffuse Large B-cell Lymphoma Recurrent Trial in Worldwide (Loncastuximab tesirine)

Completed
Has Results
  • Diffuse Large B-Cell Lymphoma Refractory
  • Diffuse Large B-cell Lymphoma Recurrent
  • Loncastuximab tesirine
  • Duarte, California
  • +36 more
Aug 18, 2022

Hemolytic Anemia Trial in Lebanon (Daratumumab / Hyaluronidase Injection)

Recruiting
  • Hemolytic Anemia
  • Daratumumab / Hyaluronidase Injection
  • Lebanon, New Hampshire
    Dartmouth-Hitchcock Medical Center
Jun 15, 2022